Offer - Urjas Oil for just ₹ 1 X
Lobate GN is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Lobate GN safe for pregnant women?
Lobate GN has many dangerous side effects in pregnant women. If you are pregnant, do not consume Lobate GN without medical advice.
Is the use of Lobate GN safe during breastfeeding?
Lobate GN can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Lobate GN on the Kidneys?
Lobate GN rarely harms the kidneys.
What is the effect of Lobate GN on the Liver?
Lobate GN is completely safe for the liver.
What is the effect of Lobate GN on the Heart?
Using Lobate GN does not have any harmful effects on the heart.
Lobate GN should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lobate GN unless your doctor advises you to do so -
Is this Lobate GN habit forming or addictive?
Lobate GN is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Lobate GN, you should not drive or work on any heavy machine, as Lobate GN can make you drowsy.
Is it safe?
Yes, but take Lobate GN only as per medical advice.
Is it able to treat mental disorders?
No, Lobate GN cannot treat any kind of mental disorder.
Interaction between Food and Lobate GN
Taking Lobate GN with food is safe.
Interaction between Alcohol and Lobate GN
Due to lack of research, there is no information about the side effects of taking Lobate GN with alcohol.
No, Lobate GN alone should not be used for ringworm because it is a fungal infection of the skin caused by fungi such as Trichophyton rubrum and Epidermophyton floccosum and Lobate GN is not an antifungal agent and it is not effective against fungi. Hence Lobate GN should not be used for the treatment of ringworm. For the treatment of ringworm, you can use a combination of Lobate GN and antifungal drugs such as miconazole and fluconazole.
Yes, Lobate GN might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Lobate GN can be absorbed by the skin.
Yes, Lobate GN might lighten skin because it causes skin atrophy (skin thinning) which reduces the darkness of the skin. However, Lobate GN is not approved for skin lightening and should not be used for this purpose because it can cause unpleasant side effects.
No, Lobate GN is a prescription drug, so do not use it without consulting a doctor. It can be harmful for the patient to use this medicine without a doctor's recommendation because it can cause unpleasant side effects. Hence, the patient should seek doctors advice before using this medication by himself or herself.
Yes, Lobate GN may cause skin discoloration or color changes. It is a rare side effect of this drug. However, the exact cause behind skin discoloration is not known but it is more likely to occur if the skin is covered with a dressing after applying this drug. So you are advised to not cover your skin with a dressing after applying this drug.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)